آخر تحديث :
19/11/2024
مضاد حيوي   Oxacillin sodium  
حقن
الاستقرار في حلول استقرار مخاليط العوامل التي تؤثر على الاستقرار التوافق طريقة التعاطي مراجع pdf
   التركيب الكيميائي  

حجز الاسم التجاري   حجز الاسم التجاري     

تحذير الأسماء التجاريه المختلفه قد تحتوي علي محتوي إضافات مختلفة حسب الدوله و المعمل

Bactocill الولايات المتحدة
Bioxalin بيرو
Bristopen المغرب
Istopen فرنسا
Lioxac بيرو
Oxacil تونس
Oxacilil البرازيل
Oxacilina الإكوادور, البرازيل, بيرو, رومانيا, فنزويلا, كولومبيا
Oxacillin الولايات المتحدة
Oxacip فنزويلا
Oxalin بيرو
Oxamicin فنزويلا
Oxanon البرازيل
Oxipen فنزويلا
Pebenal فنزويلا
Staphymicine المغرب
مراجع   حقن   مراجع : Oxacillin sodium  
نوع منشور
13 مجلة Stiles ML, Allen LV.
Stability of nafcillin sodium, oxacillin sodium, penicillin G potassium, penicillin G sodium and tobramycin sulfate in polyvinyl chloride drug reservoirs.
Am J Health-Syst Pharm 1997 ; 54: 1068-1070.
73 مجلة Lor E, Takagi J.
Visual compatibility of foscarnet with other injectable drugs.
Am J Hosp Pharm 1990 ; 47: 157-159.
150 مجلة Aujoulat P, Coze C, Braguer D, Raybaud C.
Physicochemical compatibility of methotrexate with co-administered drugs during cancer chemotherapy regimens.
J Pharm Clin 1993 ; 12: 31-35.
198 مجلة Gayed AA, Kheshary PR, Hinkle RL.
Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection.
Am J Health-Syst Pharm 1995 ; 52: 516-520.
336 مجلة Forman JK, Lachs JR, Souney PF.
Visual compatibility of acyclovir sodium with commonly used intravenous drugs during simulated Y-site injection.
Am J Hosp Pharm 1987 ; 44: 1408-1409.
337 مجلة Bashaw ED, Amantea MA, Minor JR, Galleli JF.
Visual compatibility of zidovudine with other drugs during simulated Y-site administration.
Am J Hosp Pharm 1988 ; 45: 2532-2533.
371 مجلة Thompson DF, Stiles ML, Allen LV, Tu YH.
Compatibility of verapamil hydrochloride with penicillin admixtures during simulated Y-site injection.
Am J Hosp Pharm 1988 ; 45: 142-145.
386 مجلة Colucci RD, Cobuzzi LE, Halpern NA.
Visual compatibility of labetalol hydrochloride injection with various injectable drugs during simulated Y-site injection.
Am J Hosp Pharm 1988 ; 45: 1357-1358.
397 مجلة Fong PA, Ward J.
Visual compatibility of intravenous famotidine with selected drugs.
Am J Hosp Pharm 1989 ; 46: 125-126.
405 مجلة Nieves-Cordero AL, Luciw HM, Souney PF.
Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection.
Am J Hosp Pharm 1985 ; 42: 1108-1109.
479 مجلة Min DI, Brown T, HWang GC.
Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 2964-2966.
496 مجلة Lor E, Sheybani T, Takagi J.
Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration.
Am J Hosp Pharm 1991 ; 48: 744-746.
576 مجلة Holmes CJ, Ausman RK, Walter CW, Kundsin RB.
Activity of antibiotic admixtures subjected to different freeze-thaw treatments.
Drug Intell Clin Pharm 1980 ; 14: 353-357.
604 مختبر Stabilité des médicaments dans l'Intermate® SV50, 100, 200
Baxter 1998
738 مجلة Gardella LA, Kesler H, Amann A, Carter JE.
Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 3: Stability with miscellaneous additives.
Am J Hosp Pharm 1978 ; 35: 581-584.
999 مجلة Watson D.
Piggyback compatibility of antibiotics with pediatric parenteral nutrition solution.
JPEN 1985 ; 9: 220-224.
1047 مجلة Souney PF, Colucci RD, Mariani G, Campbell D.
Compatibility of magnesium sulfate solutions with various antibiotics during simulated Y-site injection.
Am J Hosp Pharm 1984 ; 41: 323-324.
1057 مجلة Cutie MR.
Compatibility of verapamil hydrochloride injection with commonly used additives.
Am J Hosp Pharm 1983 ; 40: 1205-1207.
1072 مجلة Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA.
Compatibility of levofloxacin with 34 medications during simulated Y-site administration.
Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1135 مجلة Baltz JK, Kennedy P, Minor JR, Gallelli J.
Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration.
Am J Hosp Pharm 1990 ; 47: 2075-2077.
1228 مجلة Allen LV, Stiles ML.
Compatibility of various admixtures at Y-injection sites of intravenous administration sets. Part2.
Am J Hosp Pharm 1981 ; 38: 380-381.
1705 مجلة Zhang Y, Trissel LA.
Stability of ampicillin sodium, nafcillin sodium, and oxacillin sodium in autodose system bags.
Int J Pharm Compound 2002 ; 6: 226-229.
1802 مجلة Bell MS, Nolt DH.
Visual compatibility of doxapram hydrochloride with drugs commonly administered via a Y-site in the intensive care nursery.
Am J Health-Syst Pharm 2003 ; 60: 193-194.
3227 مجلة Simon B, Hancu G, Gy?resi A.
Application of capillary electrophoresis to the simultaneous determination and stability study of four extensively used penicillin derivatives
Braz J Pharm Sci 2014 ; 50, 3 : 521-527.
3520 مختبر Cidomycin - Summary of product Chracteristics.
Sanofi 2011
3529 مختبر Ciprofloxacin – Summary of Product Characteristics
Hospira 2013
3549 مختبر Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3580 مختبر Cytarabine Accord - Résumé des caractéristiques du produit
Accord Healthcare France 2016
3589 مختبر Oxacilline PanPharma – Résumé des caractéristiques du produits
PanPharma 2013
3638 مختبر Dopamin (Dopamine 40 mg/mL sterile concentrate®) - Summary of Product Characteristics
Hospira 2010
3643 مختبر Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
3674 مختبر Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3813 مجلة Teibel H.M, Knoderer C.A, Nichols K.R.
Compatibility of Vancomycin and Oxacillin During Simulated Y-Site Delivery.
Hosp Pharm 2015 ; 50, 8: 710-713.

  Mentions Légales